✦ LIBER ✦

OP047 FLUID THERAPY DURATION AND NUTRITIONAL STATUS INFLUENCE OUTCOME IN MEDICAL HOSPITALIZED PATIENTS

✍ Scribed by A. Calleja Fernández; G. Kyriakos; D. Ávila Turcios; M.D. Balesteros Pomar; I. Cano Rodríguez; A. Vidal Casariego

Book ID: 118654763
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 54 KB
Volume: 7
Category: Article
ISSN: 1744-1161
DOI: 10.1016/s1744-1161(12)70048-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative Nutritional Status and Othe

Preoperative Nutritional Status and Other Factors That Influence Surgical Outcome in Patients With Crohn's Disease

✍ LINDOR, KEITH D.; FLEMING, C. RICHARD; ILSTRUP, DUANE M. 📂 Article 📅 1985 🏛 Mayo Clinic 🌐 English ⚖ 328 KB

The Impact of Nutritional Status, Nutrit

The Impact of Nutritional Status, Nutritional Risk, and Nutritional Treatment on Clinical Outcome of 2248 Hospitalized Cancer Patients: A Multi-Center, Prospective Cohort Study in Chinese Teaching Hospitals

✍ Pan, Hongming; Cai, Sanjun; Ji, Jiafu; Jiang, Zhiwei; Liang, Houjie; Lin, Feng; 📂 Article 📅 2013 🏛 Lawrence Erlbaum Associates, Inc. 🌐 English ⚖ 320 KB

Influence of NPM1 and FLT3-ITD status on

Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin

✍ Chevallier, P; Prebet, T; Pigneux, A; Hunault, M; Delaunay, J; Perry, F; Lode, L 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 193 KB

First-line therapy and methylation statu

First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients

✍ Salazar, Fernanda; Molina, Miguel Angel; Sanchez-Ronco, Maria; Moran, Teresa; Ra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 405 KB

HIV Status Does Not Influence Outcome in

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

✍ Montoto, S.; Shaw, K.; Okosun, J.; Gandhi, S.; Fields, P.; Wilson, A.; Shanyinde 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 131 KB